Rhythm Pharmaceuticals, Inc. (RYTM)
117.57
+12.80
(+12.22%)
USD |
NASDAQ |
Dec 11, 16:00
117.57
0.00 (0.00%)
After-Hours: 20:00
Rhythm Pharmaceuticals Free Cash Flow: -149.13M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Gilead Sciences, Inc. | 9.162B |
| Terns Pharmaceuticals, Inc. | -77.99M |
| Altimmune, Inc. | -66.66M |
| Viking Therapeutics, Inc. | -224.58M |
| Cidara Therapeutics, Inc. | -132.94M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -26.62M |
| Cash from Investing (Quarterly) | -246.35M |
| Cash from Financing (Quarterly) | 189.30M |
| Free Cash Flow Per Share (Quarterly) | -1.005 |
| Free Cash Flow to Equity (Quarterly) | -67.12M |
| Free Cash Flow to Firm (Quarterly) | -61.87M |
| Free Cash Flow Yield | -1.99% |